# Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

> **NCT01772004** · PHASE1 · COMPLETED · sponsor: **EMD Serono Research & Development Institute, Inc.** · enrollment: 1756 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** Avelumab

## Key facts

- **NCT ID:** NCT01772004
- **Lead sponsor:** EMD Serono Research & Development Institute, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-31
- **Primary completion:** 2019-12-16
- **Final completion:** 2019-12-16
- **Target enrollment:** 1756 (ACTUAL)
- **Last updated:** 2021-12-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01772004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01772004, "Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01772004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*